1-6 of 6
Monique C. Minnema
Close
Sort by
Journal Articles

Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia

Clinical Trials & Observations
Constantine S. Tam, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton, Björn E. Wahlin, Ramón García-Sanz, Helen McCarthy, Stephen Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jarosław Czyż, Carlos Fernández De Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trněný, Monique C. Minnema, Christian Buske, Véronique Leblond, Steven P. Treon, Judith Trotman, Binghao Wu, Yiling Yu, Zhirong Shen, Wai Y. Chan, Jingjing Schneider, Heather Allewelt, Aileen Cohen, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1639–1650.
https://doi.org/10.1182/bloodadvances.2023010906
Published: 2024
Includes: Supplemental data
Journal Articles

Wnt inhibitors reduce the unfolded protein response and enhance bortezomib-induced cell death in multiple myeloma

Ingrid Spaan, Niels van Nieuwenhuijzen, Thomas Kimman, Dedeke Rockx-Brouwer, Ralph G. Tieland, Madelon M. Maurice, Monique C. Minnema, Reinier A. Raymakers, Victor Peperzak
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1103–1107.
https://doi.org/10.1182/bloodadvances.2022008442
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy and safety of daratumumab combined with all- trans retinoic acid in relapsed/refractory multiple myeloma

Clinical Trials & Observations
Kristine A. Frerichs, Monique C. Minnema, Mark-David Levin, Annemiek Broijl, Gerard M. J. Bos, Marie José Kersten, Tuna Mutis, Christie P. M. Verkleij, Inger S. Nijhof, Patricia W. C. Maas-Bosman, Saskia K. Klein, Sonja Zweegman, Pieter Sonneveld, Niels W. C. J. van de Donk
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5128–5139.
https://doi.org/10.1182/bloodadvances.2021005220
Published: 2021
Includes: Supplemental data
Journal Articles

Direct P70S6K1 inhibition to replace dexamethasone in synergistic combination with MCL-1 inhibition in multiple myeloma

Ingrid Spaan, Laura M. Timmerman, Thomas Kimman, Anne Slomp, Marta Cuenca, Niels van Nieuwenhuijzen, Laura M. Moesbergen, Monique C. Minnema, Reinier A. Raymakers, Victor Peperzak
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2593–2607.
https://doi.org/10.1182/bloodadvances.2020003624
Published: 2021
Includes: Supplemental data
Journal Articles

αβ T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies

Clinical Trials & Observations
Moniek A. de Witte, Anke Janssen, Klaartje Nijssen, Froso Karaiskaki, Luuk Swanenberg, Anna van Rhenen, Rick Admiraal, Lotte van der Wagen, Monique C. Minnema, Eefke Petersen, Reinier A. P. Raymakers, Kasper Westinga, Trudy Straetemans, Constantijn J. M. Halkes, Jaap-Jan Boelens, Jürgen Kuball
Journal: Blood Advances
Blood Adv (2021) 5 (1): 240–249.
https://doi.org/10.1182/bloodadvances.2020002444
Published: 2021
Includes: Supplemental data
Journal Articles

Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targeting

Anne Slomp, Laura M. Moesbergen, Jia-nan Gong, Marta Cuenca, Peter A. von dem Borne, Pieter Sonneveld, David C. S. Huang, Monique C. Minnema, Victor Peperzak
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4202–4214.
https://doi.org/10.1182/bloodadvances.2019000702
Published: 2019
Includes: Supplemental data